A new study finds fewer than 30% of FDA-cleared AI medical devices reported key safety or adverse event data before approval.
Key Details
- 1Study reviewed FDA data for AI/ML devices cleared between 1995 and July 2023.
- 2Out of 691 devices analyzed, 531 were radiology-specific.
- 3Fewer than 30% of devices shared safety or adverse event information prior to clearance.
- 4Authors call for more stringent testing and clearer regulatory standards.
- 5Lack of predefined efficacy and risk standards highlighted as a critical issue.
Why It Matters
Radiology relies heavily on AI devices, making their safety and efficacy crucial to patient care. The study urges tighter oversight and transparency, which could directly impact how radiologists incorporate AI into practice.
Source
Health Imaging
Related News
•AuntMinnie
Machine Learning Model Enhances Risk Stratification for Prostate MRI
Researchers developed machine learning models that outperform PSA testing in predicting abnormal prostate MRI findings for suspected prostate cancer.
•AuntMinnie
AI's Evolving Role in Tackling Radiology Workforce Shortages
AI technologies are emerging as key tools to alleviate radiology workforce shortages by improving efficiency and supporting clinical workflows.
•Radiology Business
Multimodal LLMs Struggle with Radiology Board Image Questions
Latest multimodal large language models show limitations on image-based radiology exam questions.